HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masashi Kato Selected Research

Immunotherapy

2/2024Upregulation of IL4-induced gene 1 enzyme by B2 cells during melanoma progression impairs their antitumor properties.
4/2012T-Cell Mediated Immune Responses Induced in ret Transgenic Mouse Model of Malignant Melanoma.
11/2011Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control.
10/2011Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.
11/2009Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
7/2009Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma.
2/2004c-Kit-targeting immunotherapy for hereditary melanoma in a mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masashi Kato Research Topics

Disease

84Neoplasms (Cancer)
02/2024 - 02/2004
45Melanoma (Melanoma, Malignant)
02/2024 - 02/2004
24Prostatic Neoplasms (Prostate Cancer)
02/2024 - 05/2014
17Atrial Fibrillation
12/2023 - 01/2018
16Neoplasm Metastasis (Metastasis)
02/2024 - 05/2009
14Lower Urinary Tract Symptoms
04/2021 - 01/2012
12Hearing Loss (Hearing Impairment)
05/2020 - 08/2011
10Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
12/2020 - 01/2013
9Noninfiltrating Intraductal Carcinoma (DCIS)
09/2023 - 05/2014
9Overactive Urinary Bladder (Overactive Bladder)
01/2020 - 03/2008
9Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
05/2019 - 01/2012
8Heart Failure
07/2022 - 01/2019
7Inflammation (Inflammations)
11/2023 - 10/2011
7Pain (Aches)
08/2023 - 09/2002
6Phototoxic Dermatitis (Phototoxicity)
08/2017 - 03/2013
5Aortic Valve Stenosis (Aortic Stenosis)
01/2023 - 01/2019
5Carcinoma (Carcinomatosis)
07/2022 - 03/2013
5Skin Neoplasms (Skin Cancer)
01/2022 - 01/2011
5Breast Neoplasms (Breast Cancer)
12/2021 - 11/2008
5Urinary Incontinence
04/2021 - 01/2019
4Infections
02/2024 - 11/2017
4Margins of Excision
02/2024 - 05/2014
4Carcinogenesis
01/2022 - 06/2010
4Body Weight (Weight, Body)
01/2022 - 02/2015
4Stroke (Strokes)
01/2020 - 07/2014
4Hyperpigmentation
08/2019 - 05/2007
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2015 - 01/2011
3Hypertension (High Blood Pressure)
05/2024 - 09/2023
3Stomach Neoplasms (Stomach Cancer)
12/2023 - 12/2019
3Hypersensitivity (Allergy)
09/2023 - 04/2007
3Thrombosis (Thrombus)
06/2023 - 04/2014
3Hypoxia (Hypoxemia)
01/2023 - 09/2016
3Fibrosis (Cirrhosis)
12/2021 - 01/2016
3Renal Cell Carcinoma (Grawitz Tumor)
05/2019 - 02/2009
3Stress Urinary Incontinence
01/2019 - 07/2012
3Vitiligo
01/2018 - 02/2004
3Fatty Liver
09/2016 - 07/2014

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
07/2022 - 06/2002
21ArsenicIBA
09/2023 - 03/2003
11Biomarkers (Surrogate Marker)IBA
03/2023 - 08/2011
10Phosphotransferases (Kinase)IBA
01/2020 - 04/2002
8CytokinesIBA
09/2020 - 03/2005
8Drinking WaterIBA
01/2019 - 10/2012
7Prostate-Specific Antigen (Semenogelase)IBA
07/2022 - 10/2015
7silodosinFDA Link
04/2021 - 02/2016
6Hormones (Hormone)IBA
10/2023 - 11/2016
6MetallothioneinIBA
12/2016 - 02/2004
6LigandsIBA
01/2016 - 05/2009
6Reactive Oxygen Species (Oxygen Radicals)IBA
08/2015 - 06/2012
6Tyrosine (L-Tyrosine)FDA Link
03/2012 - 05/2007
5AntigensIBA
02/2024 - 11/2008
5enzalutamideIBA
10/2023 - 09/2020
5Tadalafil (Cialis)FDA Link
04/2021 - 01/2018
5InterleukinsIBA
01/2018 - 03/2005
5Matrix Metalloproteinases (MMPs)IBA
01/2015 - 01/2008
5Endothelin Receptors (Endothelin Receptor)IBA
01/2015 - 01/2010
4SteroidsIBA
02/2024 - 12/2018
4IronIBA
11/2023 - 03/2013
4Androgen Receptors (Androgen Receptor)IBA
10/2023 - 01/2020
4AndrogensIBA
07/2022 - 01/2020
4Docetaxel (Taxotere)FDA Link
02/2021 - 10/2015
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2020 - 01/2007
4Cysteine (L-Cysteine)FDA Link
01/2020 - 09/2002
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2019 - 10/2004
4Nitric Oxide Synthase (NO Synthase)IBA
01/2018 - 06/2012
4BariumIBA
01/2016 - 01/2011
3EnzymesIBA
02/2024 - 09/2016
3Interleukin-10 (Interleukin 10)IBA
02/2024 - 07/2009
3Brain Natriuretic Peptide (Natrecor)FDA Link
11/2023 - 01/2019
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022 - 01/2012
3Therapeutic UsesIBA
10/2021 - 09/2017
3Hemoglobins (Hemoglobin)IBA
09/2021 - 02/2016
3AlbuminsIBA
01/2020 - 01/2019
3Peptides (Polypeptides)IBA
01/2020 - 01/2008
3Melanins (Melanin)IBA
01/2019 - 02/2004
3ManganeseIBA
09/2018 - 11/2016
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2018 - 06/2012
3Proto-Oncogene Proteins c-retIBA
11/2017 - 05/2010
3Dutasteride (Avodart)FDA Link
10/2017 - 08/2014
3Estrogen ReceptorsIBA
01/2017 - 07/2015
3CholesterolIBA
09/2016 - 07/2014
3Messenger RNA (mRNA)IBA
09/2016 - 05/2005
3Neutral RedIBA
08/2015 - 12/2013
3ChemokinesIBA
02/2015 - 09/2011
3Focal Adhesion Protein-Tyrosine KinasesIBA
02/2015 - 01/2014

Therapy/Procedure

36Therapeutics
02/2024 - 02/2004
15Catheter Ablation
11/2023 - 01/2018
12Prostatectomy (Retropubic Prostatectomy)
02/2024 - 05/2014
11Castration
02/2024 - 10/2015
10Drug Therapy (Chemotherapy)
12/2023 - 03/2005
8Palliative Care (Palliative Therapy)
01/2020 - 11/2011
7Immunotherapy
02/2024 - 02/2004
6Conservative Treatment
06/2023 - 11/2017
5Radiotherapy
07/2022 - 11/2017
5Nephrectomy
01/2022 - 02/2009
3Gastrectomy
12/2023 - 12/2019
3Renal Dialysis (Hemodialysis)
09/2023 - 01/2006
3Aftercare (After-Treatment)
01/2022 - 01/2018
3Neoadjuvant Therapy
01/2022 - 05/2014
3Transcatheter Aortic Valve Replacement
01/2021 - 01/2019